#USA #New York #ETF #M.D. Sass #Concentrated Value

M.D. Sass Launches Its First ETF: A New Investment Frontier

M.D. Sass, a prominent independent asset management firm spearheaded by Martin D. Sass, has made a significant entry into the growing ETF marketplace with the launch of their inaugural exchange-traded fund, the M.D. Sass Concentrated Value ETF (Ticker: SASS). This fund is set to provide a novel investment opportunity for individuals seeking exposure to a thoughtfully curated portfolio of stocks, managed using a high conviction value strategy that has been in practice since 2019.

A Landmark Offering

The launch on March 4, 2026, represents a pivotal moment for M.D. Sass, expanding its offerings to a wider audience. Previously, the firm's Concentrated Value strategy was exclusively available to institutional clients, but with the new ETF, it can now be accessed by individual investors. Managed by Ari Sass, the firm's President, this ETF encapsulates a focused approach towards U.S. equities, prioritizing a select group of 20 to 25 large and mid-cap stocks that exhibit high potential upside based on comprehensive research.

A Commitment to Innovation

According to Martin D. Sass, the ETF reflects the firm’s long-standing history of delivering innovative investment solutions. He stated, “The liquid, transparent, and tax-efficient structure of an actively managed ETF enables us to bring our deeply researched and highest-conviction views to the investment marketplace at large.” This particular launch is set against a backdrop where the equity market is notably concentrated in AI-infrastructure stocks, making diversification and prudent risk management increasingly critical for investors.

Ari Sass emphasized that through the Concentrated Value strategy, the firm aims to uncover investment opportunities where expected earnings significantly exceed consensus forecasts. The investment team is dedicated to acting decisively based on new and evolving market information, promoting a culture of intellectual honesty and transparency.

ETF Features and Launch Details

Trading on the New York Stock Exchange, the M.D. Sass Concentrated Value ETF is launching with a robust seed capital of over $70 million amassed from existing clients and principles within the firm. This funding will provide a solid foundation for the ETF, marking a strategic expansion of M.D. Sass's value investing methodology to a broader investor base.

For potential investors, it’s vital to understand the various risks associated with investing in the ETF, including the possibility of principal loss and the inherent volatility of mid-cap stocks. Additionally, as an actively managed investment vehicle, the ETF bears risks varying from standard mutual funds, such as price discrepancies in the market and liquidity challenges.

About M.D. Sass

Founded 50 years ago, M.D. Sass has built a reputation on rigorous research and identifying unique investment opportunities often overlooked by the market. The firm currently manages assets for a diverse clientele, including public funds, corporations, endowments, and family offices. As they extend their expertise into the ETF sector, M.D. Sass is poised to redefine value investing practices for both seasoned and new investors alike.

Investors are encouraged to carefully review the ETF’s prospectus to fully understand investment objectives, risks, and fee structures before making investment decisions. The full prospectus can be obtained by contacting the firm directly or visiting their official website. This launch stands as a testament to M.D. Sass’s commitment to innovation and investor accessibility within the dynamic financial landscape.